GenScript Biotech Corporation has added the AmMag(TM) Quatro automated plasmid purification system to its lab and research product line-up. The system streamlines maxi-scale plasmid purification and reduces the manpower and time needed to purify high-quality, transfection-grade plasmid. Since its introduction, AmMag Quatro has been used at the forefront of biotech research, including breakthrough projects such as viral vector development for cell engineering and gene therapy.

Ensuring the availability of high-quality, transinfection-ready plasmids is of paramount importance for the success of biotechnological research and development. However, traditional plasmid purification methods are highly labor-intensive, efficient, and prone to costly human or process errors. These manual methods not only demand excessive labor and time but also impose limitations in terms of large-scale cultures, throughput, result consistency, and the risk of contamination.

Consequently, plasmid purification has emerged as a significant process bottleneck at numerous laboratories. Meanwhile, demand for high-quality, transfections-ready plasmids has skyrocketed because plasmid DNA from bacteria is an essential component of genetic engineering and other biotechnology applications, such as cloning, transfection, and gene therapy. The need for an automated, large-scale plasmid purization solution -- one that can deliver superior- quality DNA with enhanced efficiency and unparalleled reproducibility, effectively addressing the shortcomings of current approaches -- has become increasingly evident.

For research laboratories, the AmMag Quatro system is a game-changing addition to their arsenal of advanced equipment, offering scientists in academic, pharmaceutical and biotech settings a reliable and efficient way to purify high- quality, transfection-grade Plasmids at scale; the AmMag Quatro system shortens the cycle of obtaining crucial plasmids through an efficient and expedient purification process.